NASDAQ · ASTH
Astrana Health, Inc.
$36.62-$0.05 (-0.14%)
Astrana Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.03% below the high.
Loading market information…
NASDAQ · PRVA · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Privia Health Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 23.68% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Privia Health Group, Inc.’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of $0.09. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Privia Health Group, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization, and improve care coordination and patient quality metrics, thereby advancing value-based care; and a network connecting providers with new patient populations and enabling custom contracts with purchasers and payers. Founded in 2007, the company's headquarters are located in Arlington, Virginia. Privia Health Group, Inc. was formerly a subsidiary of Brighton Health Group Holdings, LLC.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 8, 2025 | $0.03-50.0% vs estimate | $480.10M+4.69% vs estimate |
|---|
| Q4 2024 | Feb 27, 2025 | $0.03-40.0% vs estimate | $460.90M-4.08% vs estimate |
|---|
| Q3 2024 | Nov 7, 2024 | $0.03-40.0% vs estimate | $437.92M+4.14% vs estimate |
|---|
THE ANALYST VIEW
22 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 2 contributors · Median target $28.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$36.62-$0.05 (-0.14%)
Astrana Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.03% below the high.
$8.73+$1.85 (+26.89%)
Teladoc Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.73% below the high.
$85.94-$5.06 (-5.56%)
Agilon Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 35.4% below the high.
$19.65+$0.47 (+2.45%)
Omada Health’s quoted price sits in the upper half of its reported 52-week range, 24.8% below the high.
$12.53+$0.16 (+1.29%)
Phreesia, Inc.’s quoted price sits in the lower half of its reported 52-week range, 47.31% below the high.
$4.25-$0.08 (-1.85%)
Evolent Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 40.14% below the high.
$14.98+$0.86 (+6.09%)
American Well Corporation’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
$1.79-$0.01 (-0.56%)
Health Catalyst, Inc.’s quoted price sits in the lower half of its reported 52-week range, 46.88% below the high.
